Skip to content
2000
Volume 32, Issue 16
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

The most prevalent and severe malignancy of the central nervous system within the brain is glioma. Glioma is a vascularized cancer, and angiogenesis is necessary for glioma growth, invasion, and recurrence. It is also believed that this factor is this factor to be accountable for therapy resistance in many cancers, including glioma. The process of angiogenesis, which plays a crucial role in both health and disease situations such as cancer, involves the creation of new blood vessels from pre-existing ones. Non-coding RNAs (ncRNAs) are unique molecules that have been found to possess a wide range of abilities to modify the expression of various genes. They carry out their gene-modulating roles at a variety of distinct levels, including post-transcriptional and post-translational levels. Long ncRNAs (lncRNAs) and circular RNAs (circRNAs) are a group of ncRNA that have attracted particular attention and are involved in the angiogenesis mechanism in cancer. Understanding the regulatory mechanisms of these RNAs in the angiogenesis process in gliomas provides unique fundamental information about the process of tumor-associated neovascularization. On the other hand, due to developments in the characterisation of lncRNAs and circRNAs, these novel structures may potentially be used in clinics as possible biomarkers for treatment strategies that target tumor angiogenesis. Throughout the review, new knowledge and views about the angioregulatory function of circRNAs and lncRNAs in gliomas have been presented. Additionally, we talk about the novel idea of ncRNA-based therapeutics for gliomas in the future.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673259378231031061149
2024-01-22
2026-02-23

  • From This Site

    /content/journals/cmc/10.2174/0109298673259378231031061149
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MolinaroA.M. TaylorJ.W. WienckeJ.K. WrenschM.R. Genetic and molecular epidemiology of adult diffuse glioma.Nat. Rev. Neurol.201915740541710.1038/s41582‑019‑0220‑231227792
     [Google Scholar]
  2. DolecekT.A. ProppJ.M. StroupN.E. KruchkoC. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.Neuro. Oncol.201214Suppl 5v149
     [Google Scholar]
  3. QuailD.F. JoyceJ.A. The microenvironmental landscape of brain tumors.Cancer Cell201731332634110.1016/j.ccell.2017.02.00928292436
     [Google Scholar]
  4. BianE.B. ChenE.F. XuY.D. YangZ.H. TangF. MaC.C. WangH.L. ZhaoB. Exosomal lncRNA-ATB activates astrocytes that promote glioma cell invasion.Int. J. Oncol.201954271372130483768
     [Google Scholar]
  5. ChiodoniC. Di MartinoM.T. ZazzeroniF. CaragliaM. DonadelliM. MeschiniS. LeonettiC. ScotlandiK. Cell communication and signaling: How to turn bad language into positive one.BioMed Central2019
     [Google Scholar]
  6. QuezadaC. TorresÁ. NiechiI. UribeD. Contreras-DuarteS. ToledoF. San MartínR. GutiérrezJ. SobreviaL. Role of extracellular vesicles in glioma progression.Mol. Aspects Med.201860385110.1016/j.mam.2017.12.00329222067
     [Google Scholar]
  7. TakanoS. YamashitaT. OhnedaO. Molecular therapeutic targets for glioma angiogenesis.J. Oncol.2010201011110.1155/2010/35190820414463
     [Google Scholar]
  8. ChengJ. MengJ. ZhuL. PengY. Exosomal noncoding RNAs in Glioma: Biological functions and potential clinical applications.Mol. Cancer20201916610.1186/s12943‑020‑01189‑332213181
     [Google Scholar]
  9. TrepsL. PerretR. EdmondS. RicardD. GavardJ. Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles.J. Extracell. Vesicles201761135947910.1080/20013078.2017.135947928815003
     [Google Scholar]
  10. SkogJ. WürdingerT. van RijnS. MeijerD.H. GaincheL. CurryW.T.Jr CarterB.S. KrichevskyA.M. BreakefieldX.O. BreakefieldX.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.Nat. Cell Biol.200810121470147610.1038/ncb180019011622
     [Google Scholar]
  11. LuceroR. ZappulliV. SammarcoA. MurilloO.D. CheahP.S. SrinivasanS. TaiE. TingD.T. WeiZ. RothM.E. LaurentL.C. KrichevskyA.M. BreakefieldX.O. MilosavljevicA. Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells.Cell Rep.202030720652074.e410.1016/j.celrep.2020.01.07332075753
     [Google Scholar]
  12. RupaimooleR. SlackF.J. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.Nat. Rev. Drug Discov.201716320322210.1038/nrd.2016.24628209991
     [Google Scholar]
  13. WaterstonR.H. Lindblad-TohK. BirneyE. RogersJ. AbrilJ.F. AgarwalP. AgarwalaR. AinscoughR. AlexanderssonM. AnP. AntonarakisS.E. AttwoodJ. BaertschR. BaileyJ. BarlowK. BeckS. BerryE. BirrenB. BloomT. BorkP. BotcherbyM. BrayN. BrentM.R. BrownD.G. BrownS.D. BultC. BurtonJ. ButlerJ. CampbellR.D. CarninciP. CawleyS. ChiaromonteF. ChinwallaA.T. ChurchD.M. ClampM. CleeC. CollinsF.S. CookL.L. CopleyR.R. CoulsonA. CouronneO. CuffJ. CurwenV. CuttsT. DalyM. DavidR. DaviesJ. DelehauntyK.D. DeriJ. DermitzakisE.T. DeweyC. DickensN.J. DiekhansM. DodgeS. DubchakI. DunnD.M. EddyS.R. ElnitskiL. EmesR.D. EswaraP. EyrasE. FelsenfeldA. FewellG.A. FlicekP. FoleyK. FrankelW.N. FultonL.A. FultonR.S. FureyT.S. GageD. GibbsR.A. GlusmanG. GnerreS. GoldmanN. GoodstadtL. GrafhamD. GravesT.A. GreenE.D. GregoryS. GuigóR. GuyerM. HardisonR.C. HausslerD. HayashizakiY. HillierL.W. HinrichsA. HlavinaW. HolzerT. HsuF. HuaA. HubbardT. HuntA. JacksonI. JaffeD.B. JohnsonL.S. JonesM. JonesT.A. JoyA. KamalM. KarlssonE.K. KarolchikD. KasprzykA. KawaiJ. KeiblerE. KellsC. KentW.J. KirbyA. KolbeD.L. KorfI. KucherlapatiR.S. KulbokasE.J. KulpD. LandersT. LegerJ.P. LeonardS. LetunicI. LevineR. LiJ. LiM. LloydC. LucasS. MaB. MaglottD.R. MardisE.R. MatthewsL. MauceliE. MayerJ.H. McCarthyM. McCombieW.R. McLarenS. McLayK. McPhersonJ.D. MeldrimJ. MeredithB. MesirovJ.P. MillerW. MinerT.L. MonginE. MontgomeryK.T. MorganM. MottR. MullikinJ.C. MuznyD.M. NashW.E. NelsonJ.O. NhanM.N. NicolR. NingZ. NusbaumC. O’ConnorM.J. OkazakiY. OliverK. Overton-LartyE. PachterL. ParraG. PepinK.H. PetersonJ. PevznerP. PlumbR. PohlC.S. PoliakovA. PonceT.C. PontingC.P. PotterS. QuailM. ReymondA. RoeB.A. RoskinK.M. RubinE.M. RustA.G. SantosR. SapojnikovV. SchultzB. SchultzJ. SchwartzM.S. SchwartzS. ScottC. SeamanS. SearleS. SharpeT. SheridanA. ShownkeenR. SimsS. SingerJ.B. SlaterG. SmitA. SmithD.R. SpencerB. StabenauA. Stange-ThomannN. SugnetC. SuyamaM. TeslerG. ThompsonJ. TorrentsD. TrevaskisE. TrompJ. UclaC. Ureta-VidalA. VinsonJ.P. Von NiederhausernA.C. WadeC.M. WallM. WeberR.J. WeissR.B. WendlM.C. WestA.P. WetterstrandK. WheelerR. WhelanS. WierzbowskiJ. WilleyD. WilliamsS. WilsonR.K. WinterE. WorleyK.C. WymanD. YangS. YangS.P. ZdobnovE.M. ZodyM.C. LanderE.S. Initial sequencing and comparative analysis of the mouse genome.Nature2002420691552056210.1038/nature0126212466850
     [Google Scholar]
  14. OlsenA. Initial sequencing and analysis of the human genome.Nature.20014096822860921
     [Google Scholar]
  15. CarninciP. KasukawaT. KatayamaS. GoughJ. FrithM. MaedaN. OyamaR. RavasiT. LenhardB. WellsC. The transcriptional landscape of the mammalian genome.Science2005309574015591563
     [Google Scholar]
  16. ConsortiumI. A haplotype map of the human genome.Nature200543770631299132010.1038/nature0422616255080
     [Google Scholar]
  17. ConsortiumE.P. ENCODE Project Consortium An integrated encyclopedia of DNA elements in the human genome.Nature20124897414577410.1038/nature1124722955616
     [Google Scholar]
  18. AnastasiadouE. JacobL.S. SlackF.J. Non-coding RNA networks in cancer.Nat. Rev. Cancer201818151810.1038/nrc.2017.9929170536
     [Google Scholar]
  19. KoppF. MendellJ.T. Functional classification and experimental dissection of long noncoding RNAs.Cell2018172339340710.1016/j.cell.2018.01.01129373828
     [Google Scholar]
  20. IyerM.K. NiknafsY.S. MalikR. SinghalU. SahuA. HosonoY. BarretteT.R. PrensnerJ.R. EvansJ.R. ZhaoS. PoliakovA. CaoX. DhanasekaranS.M. WuY.M. RobinsonD.R. BeerD.G. FengF.Y. IyerH.K. ChinnaiyanA.M. The landscape of long noncoding RNAs in the human transcriptome.Nat. Genet.201547319920810.1038/ng.319225599403
     [Google Scholar]
  21. RinnJ.L. KerteszM. WangJ.K. SquazzoS.L. XuX. BrugmannS.A. GoodnoughL.H. HelmsJ.A. FarnhamP.J. SegalE. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs.Cell2007129713111323
     [Google Scholar]
  22. MondalT. SubhashS. VaidR. EnrothS. UdayS. ReiniusB. MitraS. MohammedA. JamesA.R. HobergE. MoustakasA. GyllenstenU. JonesS.J.M. GustafssonC.M. SimsA.H. WesterlundF. GorabE. KanduriC. MEG3 long noncoding RNA regulates the TGF-β pathway genes through formation of RNA–DNA triplex structures.Nat. Commun.201561774310.1038/ncomms874326205790
     [Google Scholar]
  23. LeucciE. VendraminR. SpinazziM. LauretteP. FiersM. WoutersJ. RadaelliE. EyckermanS. LeonelliC. VanderheydenK. RogiersA. HermansE. BaatsenP. AertsS. AmantF. Van AelstS. van den OordJ. de StrooperB. DavidsonI. LafontaineD.L.J. GevaertK. VandesompeleJ. MestdaghP. MarineJ.C. Melanoma addiction to the long non-coding RNA SAMMSON.Nature2016531759551852210.1038/nature1716127008969
     [Google Scholar]
  24. LegniniI. Di TimoteoG. RossiF. MorlandoM. BrigantiF. SthandierO. FaticaA. SantiniT. AndronacheA. WadeM. LaneveP. RajewskyN. BozzoniI. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis.Mol. Cell20176612237.e910.1016/j.molcel.2017.02.01728344082
     [Google Scholar]
  25. VoJ.N. CieslikM. ZhangY. ShuklaS. XiaoL. ZhangY. WuY.M. DhanasekaranS.M. EngelkeC.G. CaoX. RobinsonD.R. NesvizhskiiA.I. ChinnaiyanA.M. The landscape of circular RNA in cancer.Cell20191764869881.e1310.1016/j.cell.2018.12.02130735636
     [Google Scholar]
  26. CieślikM. ChinnaiyanA.M. Cancer transcriptome profiling at the juncture of clinical translation.Nat. Rev. Genet.20181929310910.1038/nrg.2017.9629279605
     [Google Scholar]
  27. OliverG. Lymphatic vasculature development.Nat. Rev. Immunol.200441354510.1038/nri125814704766
     [Google Scholar]
  28. Moreira-SoaresM. CoimbraR. RebeloL. CarvalhoJ. D M TravassoR. Angiogenic factors produced by hypoxic cells are a leading driver of anastomoses in sprouting angiogenesis-a computational study.Sci. Rep.201881872610.1038/s41598‑018‑27034‑829880828
     [Google Scholar]
  29. FolkmanJ. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.N. Engl. J. Med.1995333261757176310.1056/NEJM1995122833326087491141
     [Google Scholar]
  30. De SpiegelaereW. CasteleynC. Van den BroeckW. PlendJ. BahramsoltaniM. SimoensP. DjonovV. CornillieP. Intussusceptive angiogenesis: A biologically relevant form of angiogenesis.J. Vasc. Res.201249539040410.1159/00033827822739226
     [Google Scholar]
  31. RisauW. FlammeI. Vasculogenesis.Annu. Rev. Cell Dev. Biol.1995111739110.1146/annurev.cb.11.110195.0004458689573
     [Google Scholar]
  32. CarmelietP. Angiogenesis in health and disease.Nat. Med.20039665366010.1038/nm0603‑65312778163
     [Google Scholar]
  33. ZimnaA. KurpiszM. Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: Applications and therapies.BioMed Res. Int.2015201511310.1155/2015/54941226146622
     [Google Scholar]
  34. ChungA.S. LeeJ. FerraraN. Targeting the tumour vasculature: Insights from physiological angiogenesis.Nat. Rev. Cancer201010750551410.1038/nrc286820574450
     [Google Scholar]
  35. SalajeghehA. Adenosine Triphosphate-Binding Cassette (ABC) Lipid Transporters. Angiogenesis in Health, Disease and Malignancy. SalajeghehA. ChamSpringer International Publishing2016111510.1007/978‑3‑319‑28140‑7_2
     [Google Scholar]
  36. FerraraN. Vascular endothelial growth factor as a target for anticancer therapy.Oncologist20049S121010.1634/theoncologist.9‑suppl_1‑215178810
     [Google Scholar]
  37. DeshpandeM. MegarityH. NuseT. NazareT. SemenzaG. SodhiS.M. SodhiA. Hypoglycemia promotes pathological angiogenesis by a p38-dependent increase in hypoxia inducible factor-1α nuclear accumulation.Invest. Ophthalmol. Vis. Sci.202061717621762
     [Google Scholar]
  38. SamanH. RazaS.S. UddinS. RasulK. Inducing angiogenesis, a key step in cancer vascularization, and treatment approaches.Cancers2020125
     [Google Scholar]
  39. BalukP. HashizumeH. McDonaldD.M. Cellular abnormalities of blood vessels as targets in cancer.Curr. Opin. Genet. Dev.200515110211110.1016/j.gde.2004.12.00515661540
     [Google Scholar]
  40. FolkinsC. ShakedY. ManS. TangT. LeeC.R. ZhuZ. HoffmanR.M. KerbelR.S. Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1.Cancer Res.200969187243725110.1158/0008‑5472.CAN‑09‑016719738068
     [Google Scholar]
  41. NagyJ. ChangS.H. ShihS.C. DvorakA. DvorakH. Heterogeneity of the tumor vasculature.Semin. Thromb. Hemost.201036332133110.1055/s‑0030‑125345420490982
     [Google Scholar]
  42. BaishJ.W. StylianopoulosT. LanningR.M. KamounW.S. FukumuraD. MunnL.L. JainR.K. Scaling rules for diffusive drug delivery in tumor and normal tissues.Proc. Natl. Acad. Sci. USA201110851799180310.1073/pnas.101815410821224417
     [Google Scholar]
  43. LeeS.H. JeungI.C. ParkT.W. LeeK. LeeD.G. ChoY.L. LeeT.S. NaH.J. ParkY.J. LeeH.G. JeongM.S. BaeK.H. LeeS.C. LeeH.J. KwonY.G. HongH.J. KimJ.S. MinJ.K. Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma.Oncotarget2015697182719410.18632/oncotarget.312125762629
     [Google Scholar]
  44. AhirB.K. EngelhardH.H. LakkaS.S. Tumor development and angiogenesis in adult brain tumor: Glioblastoma.Mol. Neurobiol.20205752461247810.1007/s12035‑020‑01892‑832152825
     [Google Scholar]
  45. RibattiD. PezzellaF. Vascular co-option and other alternative modalities of growth of tumor vasculature in glioblastoma.Front. Oncol.20221287455410.3389/fonc.2022.87455435433447
     [Google Scholar]
  46. AldapeK. ZadehG. MansouriS. ReifenbergerG. von DeimlingA. Glioblastoma: Pathology, molecular mechanisms and markers.Acta Neuropathol.2015129682984810.1007/s00401‑015‑1432‑125943888
     [Google Scholar]
  47. HuQ. LiuF. YanT. WuM. YeM. ShiG. LvS. ZhuX. MicroRNA-576-3p inhibits the migration and proangiogenic abilities of hypoxia-treated glioma cells through hypoxia-inducible factor-1α.Int. J. Mol. Med.20194362387239710.3892/ijmm.2019.415731017266
     [Google Scholar]
  48. ArvanitisC.D. FerraroG.B. JainR.K. The blood–brain barrier and blood–tumour barrier in brain tumours and metastases.Nat. Rev. Cancer2020201264110.1038/s41568‑019‑0205‑x31601988
     [Google Scholar]
  49. DasS. MarsdenP.A. Angiogenesis in glioblastoma.N. Engl. J. Med.2013369161561156310.1056/NEJMcibr130940224131182
     [Google Scholar]
  50. GuttmanM. AmitI. GarberM. FrenchC. LinM.F. FeldserD. HuarteM. ZukO. CareyB.W. CassadyJ.P. CabiliM.N. JaenischR. MikkelsenT.S. JacksT. HacohenN. BernsteinB.E. KellisM. RegevA. RinnJ.L. LanderE.S. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals.Nature2009458723522322710.1038/nature0767219182780
     [Google Scholar]
  51. HajjariM. KhoshnevisanA. ShinY.K. Molecular function and regulation of long non-coding RNAs: Paradigms with potential roles in cancer.Tumour Biol.20143511106451066310.1007/s13277‑014‑2636‑z25266799
     [Google Scholar]
  52. DerrienT. JohnsonR. BussottiG. TanzerA. DjebaliS. TilgnerH. GuernecG. MartinD. MerkelA. KnowlesD.G. LagardeJ. VeeravalliL. RuanX. RuanY. LassmannT. CarninciP. BrownJ.B. LipovichL. GonzalezJ.M. ThomasM. DavisC.A. ShiekhattarR. GingerasT.R. HubbardT.J. NotredameC. HarrowJ. GuigóR. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression.Genome Res.20122291775178910.1101/gr.132159.11122955988
     [Google Scholar]
  53. KapranovP. ChengJ. DikeS. NixD.A. DuttaguptaR. WillinghamA.T. StadlerP.F. HertelJ. HackermüllerJ. HofackerI.L. BellI. CheungE. DrenkowJ. DumaisE. PatelS. HeltG. GaneshM. GhoshS. PiccolboniA. SementchenkoV. TammanaH. GingerasT.R. RNA maps reveal new RNA classes and a possible function for pervasive transcription.Science200731658301484148810.1126/science.113834117510325
     [Google Scholar]
  54. DieciG. FiorinoG. CastelnuovoM. TeichmannM. PaganoA. The expanding RNA polymerase III transcriptome.Trends Genet.2007231261462210.1016/j.tig.2007.09.00117977614
     [Google Scholar]
  55. QuinnJ.J. ChangH.Y. Unique features of long non-coding RNA biogenesis and function.Nat. Rev. Genet.2016171476210.1038/nrg.2015.1026666209
     [Google Scholar]
  56. XuY. LianY. ZhangY. HuangS. ZuoQ. YangN. ChenY. WuD. SunL. The long non-coding RNA PVT1 represses ANGPTL4 transcription through binding with EZH2 in trophoblast cell.J. Cell. Mol. Med.20182221272128229193797
     [Google Scholar]
  57. LiuB. SunL. LiuQ. GongC. YaoY. LvX. LinL. YaoH. SuF. LiD. ZengM. SongE. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis.Cancer Cell201527337038110.1016/j.ccell.2015.02.00425759022
     [Google Scholar]
  58. YuanJ. YangF. WangF. MaJ. GuoY. TaoQ. LiuF. PanW. WangT. ZhouC. WangS. WangY. YangY. YangN. ZhouW. YangG. SunS. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma.Cancer Cell201425566668110.1016/j.ccr.2014.03.01024768205
     [Google Scholar]
  59. LiD. LiuX. ZhouJ. HuJ. ZhangD. LiuJ. QiaoY. ZhanQ. Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal–regulated kinase and YB-1 to enhance hepatocarcinogenesis.Hepatology20176551612162710.1002/hep.2901028027578
     [Google Scholar]
  60. LiuJ. ZhangQ. YangD. XieF. WangZ. The role of long non-coding RNAs in angiogenesis and anti-angiogenic therapy resistance in cancer.Mol. Ther. Nucleic Acids20222839740710.1016/j.omtn.2022.03.01235505957
     [Google Scholar]
  61. JinK.T. YaoJ.Y. FangX.L. DiH. MaY.Y. Roles of lncRNAs in cancer: Focusing on angiogenesis.Life Sci.202025211764710.1016/j.lfs.2020.11764732275935
     [Google Scholar]
  62. TaniueK. AkimitsuN. The functions and unique features of lncrnas in cancer development and tumorigenesis.Int. J. Mol. Sci.202122263210.3390/ijms2202063233435206
     [Google Scholar]
  63. WangJ. ZhangX. ChenW. HuX. LiJ. LiuC. Regulatory roles of long noncoding RNAs implicated in cancer hallmarks.Int. J. Cancer2020146490691610.1002/ijc.3227730873588
     [Google Scholar]
  64. MabetaP. HullR. DlaminiZ. LncRNAs and the angiogenic switch in cancer: Clinical significance and therapeutic opportunities.Genes202213115210.3390/genes1301015235052495
     [Google Scholar]
  65. ShengS.R. WuJ.S. TangY.L. LiangX.H. Long noncoding RNAs: Emerging regulators of tumor angiogenesis.Future Oncol.201713171551156210.2217/fon‑2017‑014928513194
     [Google Scholar]
  66. ZhaoJ. LiL. HanZ.Y. WangZ.X. QinL.X. Long noncoding RNAs, emerging and versatile regulators of tumor-induced angiogenesis.Am. J. Cancer Res.2019971367138131392075
     [Google Scholar]
  67. LinX. YangF. QiX. LiQ. WangD. YiT. YinR. ZhaoX. ZhongX. BianC. LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR-145.Mol. Carcinog.201958122286229610.1002/mc.2311731545000
     [Google Scholar]
  68. ZhangK. LiQ. KangX. WangY. WangS. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.Oncol. Rep.20163652911292510.3892/or.2016.507027600337
     [Google Scholar]
  69. ZhaoZ. SunW. GuoZ. ZhangJ. YuH. LiuB. Mechanisms of lncRNA/microRNA interactions in angiogenesis.Life Sci.202025411690010.1016/j.lfs.2019.11690031786194
     [Google Scholar]
  70. ChengZ. LiZ. MaK. LiX. TianN. DuanJ. XiaoX. WangY. Long non-coding RNA XIST promotes glioma tumorigenicity and angiogenesis by acting as a molecular sponge of miR-429.J. Cancer20178194106411610.7150/jca.2102429187887
     [Google Scholar]
  71. FangH. YangL. FanY. MoC. LuoL. LiangD. JiangY. Upregulation of tissue long noncoding RNA X inactive specific transcript predicts poor postoperative survival in patients with non-small cell lung cancer.Medicine20209950e2178910.1097/MD.000000000002178933327221
     [Google Scholar]
  72. ChenL. WangX. WangH. LiY. YanW. HanL. ZhangK. ZhangJ. WangY. FengY. PuP. JiangT. KangC. JiangC. miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.Eur. J. Cancer201248163104311110.1016/j.ejca.2012.02.00722406049
     [Google Scholar]
  73. LiangM.L. HsiehT.H. NgK.H. TsaiY.N. TsaiC.F. ChaoM.E. LiuD.J. ChuS.S. ChenW. LiuY.R. LiuR.S. LinS.C. HoD.M.T. WongT.T. YangM.H. WangH.W. Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high- grade gliomas.Oncotarget2016715197231973710.18632/oncotarget.773626933822
     [Google Scholar]
  74. YaoY. MaJ. XueY. WangP. LiZ. LiuJ. ChenL. XiZ. TengH. WangZ. LiZ. LiuY. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.Cancer Lett.20153591758610.1016/j.canlet.2014.12.05125578780
     [Google Scholar]
  75. YuH. XueY. WangP. LiuX. MaJ. ZhengJ. LiZ. LiZ. CaiH. LiuY. Knockdown of long non-coding RNA XIST increases blood–tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137.Oncogenesis201763e303e30310.1038/oncsis.2017.728287613
     [Google Scholar]
  76. WuC.L. HoJ.Y. HungS.H. YuD.S. miR-429 expression in bladder cancer and its correlation with tumor behavior and clinical outcome.Kaohsiung J. Med. Sci.201834633534010.1016/j.kjms.2018.01.00129747777
     [Google Scholar]
  77. ZhangM. DongB.B. LuM. ZhengM.J. ChenH. DingJ.Z. XuA-M. XuY.H. miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells.OncoTargets Ther.201691123113327042104
     [Google Scholar]
  78. FanJ. FanY. WangX. XieH. GaoH. ZhangY. LiuM. TangH. miR-429 is involved in regulation of NF -κBactivity by targeting IKK β and suppresses oncogenic activity in cervical cancer cells.FEBS Lett.2017591111812810.1002/1873‑3468.1250227883176
     [Google Scholar]
  79. MachackovaT. MlcochovaH. StanikM. DolezelJ. FedorkoM. PacikD. PoprachA. SvobodaM. SlabyO. MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition.Tumour Biol.20163711146531465810.1007/s13277‑016‑5310‑927619681
     [Google Scholar]
  80. YuW. ChenL. YangY.Q. FalckJ.R. GuoA.M. LiY. YangJ. Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.Cancer Chemother. Pharmacol.201168361962910.1007/s00280‑010‑1521‑821120482
     [Google Scholar]
  81. XuL. StevensJ. HiltonM.B. SeamanS. ConradsT.P. VeenstraT.D. LogsdonD. MorrisH. SwingD.A. PatelN.L. COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models.Sci. Trans. Med.20146242242ra84242ra84
     [Google Scholar]
  82. PetrickJ.L. SteckS.E. BradshawP.T. TriversK.F. AbrahamsonP.E. EngelL.S. HeK. ChowW-H. MayneS.T. RischH.A. VaughanT.L. GammonM.D. Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA).Br. J. Cancer201511271291130010.1038/bjc.2015.2525668011
     [Google Scholar]
  83. WangZ. WangN. HanS. WangD. MoS. YuL. HuangH. TsuiK. ShenJ. ChenJ. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway.PLoS One201387e6856610.1371/journal.pone.006856623861918
     [Google Scholar]
  84. WangC. ChenY. WangY. LiuX. LiuY. LiY. ChenH. FanC. WuD. YangJ. Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1.J. Exp. Clin. Cancer Res.201938137110.1186/s13046‑019‑1361‑231438982
     [Google Scholar]
  85. YuY. Nangia-MakkerP. FarhanaL. MajumdarA.P.N. A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells.Mol. Cancer201716115510.1186/s12943‑017‑0725‑528964256
     [Google Scholar]
  86. LingH. SpizzoR. AtlasiY. NicolosoM. ShimizuM. RedisR.S. NishidaN. GafàR. SongJ. GuoZ. IvanC. BarbarottoE. De VriesI. ZhangX. FerracinM. ChurchmanM. van GalenJ.F. BeverlooB.H. ShariatiM. HaderkF. EstecioM.R. Garcia-ManeroG. PatijnG.A. GotleyD.C. BhardwajV. ShureiqiI. SenS. MultaniA.S. WelshJ. YamamotoK. TaniguchiI. SongM.A. GallingerS. CaseyG. ThibodeauS.N. Le MarchandL. TiirikainenM. ManiS.A. ZhangW. DavuluriR.V. MimoriK. MoriM. SieuwertsA.M. MartensJ.W.M. TomlinsonI. NegriniM. Berindan-NeagoeI. FoekensJ.A. HamiltonS.R. LanzaG. KopetzS. FoddeR. CalinG.A. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.Genome Res.20132391446146110.1101/gr.152942.11223796952
     [Google Scholar]
  87. TomlinsonI. WebbE. Carvajal-CarmonaL. BroderickP. KempZ. SpainS. PenegarS. ChandlerI. GormanM. WoodW. BarclayE. LubbeS. MartinL. SellickG. JaegerE. HubnerR. WildR. RowanA. FieldingS. HowarthK. SilverA. AtkinW. MuirK. LoganR. KerrD. JohnstoneE. SieberO. GrayR. ThomasH. PetoJ. CazierJ.B. HoulstonR. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21.Nat. Genet.200739898498810.1038/ng208517618284
     [Google Scholar]
  88. HuaF. LiC.H. ChenX.G. LiuX.P. Long noncoding RNA CCAT2 knockdown suppresses tumorous progression by sponging miR-424 in epithelial ovarian cancer.Oncol. Res.201826224124710.3727/096504017X1495394867541228550684
     [Google Scholar]
  89. LiS. WuY. ZhangJ. SunH. WangX. Role of miRNA-424 in cancers.OncoTargets Ther.2020139611962210.2147/OTT.S26654133061443
     [Google Scholar]
  90. JinC. LiM. OuyangY. TanZ. JiangY. MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation.J. Neurooncol.2017133224725510.1007/s11060‑017‑2438‑428508328
     [Google Scholar]
  91. SunS.L. ShuY.G. TaoM.Y. LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424.Mol. Cell. Biochem.20204681-2698210.1007/s11010‑020‑03712‑y32236863
     [Google Scholar]
  92. WuB. ZhangY. YuY. ZhongC. LangQ. LiangZ. LvC. XuF. TianY. Long noncoding RNA H19: A novel therapeutic target emerging in oncology via regulating oncogenic signaling pathways.Front. Cell Dev. Biol.2021979674010.3389/fcell.2021.79674034977037
     [Google Scholar]
  93. YangJ. QiM. FeiX. WangX. WangK. LncRNA H19: A novel oncogene in multiple cancers.Int. J. Biol. Sci.202117123188320810.7150/ijbs.6257334421359
     [Google Scholar]
  94. JiangX. YanY. HuM. ChenX. WangY. DaiY. WuD. WangY. ZhuangZ. XiaH. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells.J. Neurosurg.2016124112913610.3171/2014.12.JNS142626274999
     [Google Scholar]
  95. ZhangT. WangY.R. ZengF. CaoH.Y. ZhouH.D. WangY.J. LncRNA H19 is overexpressed in glioma tissue, is negatively associated with patient survival, and promotes tumor growth through its derivative miR-675.Eur. Rev. Med. Pharmacol. Sci.201620234891489727981546
     [Google Scholar]
  96. YingH. ChiC. Glioma cell proliferation is inhibited by miR-342-3p, miR-377/E2F1 signaling pathway.Neoplasma201966452453110.4149/neo_2018_180805N57430868897
     [Google Scholar]
  97. CarneiroI. Quintela-VieiraF. LoboJ. Moreira-BarbosaC. MenezesF.D. MartinsA.T. OliveiraJ. SilvaR. JerónimoC. HenriqueR. Expression of EMT-related genes CAMK2N1 and WNT5A is increased in locally invasive and metastatic prostate cancer.J. Cancer201910245915592510.7150/jca.3456431762801
     [Google Scholar]
  98. BindaE. VisioliA. GianiF. TrivieriN. PalumboO. RestelliS. DeziF. MazzaT. FusilliC. LegnaniF. CarellaM. Di MecoF. DuggalR. VescoviA.L. Wnt5a drives an invasive phenotype in human glioblastoma stem-like cells.Cancer Res.2017774996100710.1158/0008‑5472.CAN‑16‑169328011620
     [Google Scholar]
  99. ZhouQ. LiuZ-Z. WuH. KuangW-L. LncRNA H19 promotes cell proliferation, migration, and angiogenesis of glioma by regulating Wnt5a/β-catenin pathway via targeting miR-342.Cell. Mol. Neurobiol.202011333161527
     [Google Scholar]
  100. LiuZ.Z. TianY.F. WuH. OuyangS.Y. KuangW.L. LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis.Neoplasma202067111111810.4149/neo_2019_190121N6131777264
     [Google Scholar]
  101. ShaH.H. WangD.D. ChenD. LiuS.W. WangZ. YanD.L. DongS.C. FengJ.F. MiR-138: A promising therapeutic target for cancer.Tumour Biol.201739410.1177/101042831769757528378633
     [Google Scholar]
  102. SongT. ZhangX. WangC. WuY. CaiW. GaoJ. HongB. MiR-138 suppresses expression of hypoxia-inducible factor 1α (HIF-1α) in clear cell renal cell carcinoma 786-O cells.Asian Pac. J. Cancer Prev.20111251307131121875287
     [Google Scholar]
  103. DaM. ZhuangJ. ZhouY. QiQ. HanS. Role of long noncoding RNA taurine-upregulated gene 1 in cancers.Mol. Med.20212715110.1186/s10020‑021‑00312‑434039257
     [Google Scholar]
  104. DaiQ. DengJ. ZhouJ. WangZ. YuanX. PanS. ZhangH. Long non-coding RNA TUG1 promotes cell progression in hepatocellular carcinoma via regulating miR-216b-5p/DLX2 axis.Cancer Cell Int.2020201810.1186/s12935‑019‑1093‑631920462
     [Google Scholar]
  105. CaiH. LiuX. ZhengJ. XueY. MaJ. LiZ. XiZ. LiZ. BaoM. LiuY. Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma.Oncogene201736331833110.1038/onc.2016.21227345398
     [Google Scholar]
  106. WangZ. LiuQ. HuangP. CaiG. miR-299-3p suppresses cell progression and induces apoptosis by downregulating PAX3 in gastric cancer.Open Life Sci.202116126627610.1515/biol‑2021‑002233817318
     [Google Scholar]
  107. MaT. WuF.H. WuH.X. FaQ. ChenY. Long non-coding RNA MCM3AP-AS1: A crucial role in human malignancies.Pathol. Oncol. Res.202228161019410.3389/pore.2022.161019435783356
     [Google Scholar]
  108. LiuB. XiangW. LiuJ. TangJ. WangJ. LiuB. LongZ. WangL. YinG. LiuJ. The regulatory role of antisense lncRNAs in cancer.Cancer Cell Int.202121145910.1186/s12935‑021‑02168‑434461912
     [Google Scholar]
  109. PeiY. YaoQ. LiY. ZhangX. XieB. microRNA-211 regulates cell proliferation, apoptosis and migration/invasion in human osteosarcoma via targeting EZRIN.Cell. Mol. Biol. Lett.20192414810.1186/s11658‑019‑0173‑x31333725
     [Google Scholar]
  110. GaoY. DingY. ChenH. ChenH. ZhouJ. Targeting Krüppel-like factor 5 (KLF5) for cancer therapy.Curr. Top. Med. Chem.201515869971310.2174/156802661566615030210505225732792
     [Google Scholar]
  111. SciorraV.A. SanchezM.A. KunibeA. WurmserA.E. Suppression of glioma progression by Egln3.PLoS One.201278e4005310.1371/journal.pone.0040053
     [Google Scholar]
  112. WangW. ZhuG. LaiS. GuoY. YinX. ChenD. WenL. Angiogenic factor with G Patch and FHA domains 1 (AGGF1) acts as diagnostic biomarker and adverse prognostic factor of Hepatocellular Carcinoma (HCC): Evidence from bioinformatic analysis.Med. Sci. Monit.202026e919896e110.12659/MSM.91989632090983
     [Google Scholar]
  113. YangC. ZhengJ. XueY. YuH. LiuX. MaJ. LiuL. WangP. LiZ. CaiH. LiuY. The effect of MCM3AP-AS1/miR-211/KLF5/AGGF1 axis regulating glioblastoma angiogenesis.Front Mol Neurosci201710437
     [Google Scholar]
  114. KristensenL.S. AndersenM.S. StagstedL.V.W. EbbesenK.K. HansenT.B. KjemsJ. The biogenesis, biology and characterization of circular RNAs.Nat. Rev. Genet.2019201167569110.1038/s41576‑019‑0158‑731395983
     [Google Scholar]
  115. MemczakS. JensM. ElefsiniotiA. TortiF. KruegerJ. RybakA. MaierL. MackowiakS.D. GregersenL.H. MunschauerM. LoewerA. ZieboldU. LandthalerM. KocksC. le NobleF. RajewskyN. Circular RNAs are a large class of animal RNAs with regulatory potency.Nature2013495744133333810.1038/nature1192823446348
     [Google Scholar]
  116. HsiaoK.Y. SunH.S. TsaiS.J. Circular RNA-New member of noncoding RNA with novel functions.Exp. Biol. Med.2017242111136114110.1177/153537021770897828485684
     [Google Scholar]
  117. LiX. YangL. ChenL.L. The biogenesis, functions, and challenges of circular RNAs.Mol. Cell201871342844210.1016/j.molcel.2018.06.03430057200
     [Google Scholar]
  118. LiuC.G. LiJ. XuY. LiW. FangS.X. ZhangQ. XinH.W. MaZ. Long non-coding RNAs and circular RNAs in tumor angiogenesis: From mechanisms to clinical significance.Mol. Ther. Oncolytics20212233635410.1016/j.omto.2021.07.00134553023
     [Google Scholar]
  119. LiJ. SunD. PuW. WangJ. PengY. Circular RNAs in cancer: Biogenesis, function, and clinical significance.Trends Cancer20206431933610.1016/j.trecan.2020.01.01232209446
     [Google Scholar]
  120. LiuY. YangY. WangZ. FuX. ChuX. LiY. WangQ. HeX. LiM. WangK. WangJ. LiP. YuT. Insights into the regulatory role of circRNA in angiogenesis and clinical implications.Atherosclerosis2020298142610.1016/j.atherosclerosis.2020.02.01732131039
     [Google Scholar]
  121. YangW. DuW.W. LiX. YeeA.J. YangB.B. Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis.Oncogene201635303919393110.1038/onc.2015.46026657152
     [Google Scholar]
  122. ShaoY. LuB. The crosstalk between circular RNAs and the tumor microenvironment in cancer metastasis.Cancer Cell Int.202020144810.1186/s12935‑020‑01532‑032943996
     [Google Scholar]
  123. SangC. RaoD. WuC. XiaY. SiM. TangZ. Role of circular RNAs in the diagnosis, regulation of drug resistance and prognosis of lung cancer (Review).Oncol. Lett.202224330210.3892/ol.2022.1342235949591
     [Google Scholar]
  124. HeQ. ZhaoL. LiuY. LiuX. ZhengJ. YuH. CaiH. MaJ. LiuL. WangP. LiZ. XueY. circ-SHKBP1 regulates the angiogenesis of U87 glioma-exposed endothelial cells through miR-544a/FOXP1 and miR-379/FOXP2 pathways.Mol. Ther. Nucleic Acids20181033134810.1016/j.omtn.2017.12.01429499945
     [Google Scholar]
  125. Ghafouri-FardS. ShaterabadiD. AbakA. ShooreiH. BahroudiZ. TaheriM. MousavinejadS.A. An update on the role of miR-379 in human disorders.Biomed. Pharmacother.202113911155310.1016/j.biopha.2021.11155333845370
     [Google Scholar]
  126. LuP. GuY. LiL. WangF. QiuX. miR-544a promotes breast cancer cell migration and invasion reducing cadherin 1 expression.Oncol. Res.201623416517010.3727/096504016X1451915790272627053345
     [Google Scholar]
  127. LehmannO.J. SowdenJ.C. CarlssonP. JordanT. BhattacharyaS.S. Fox’s in development and disease.Trends Genet.200319633934410.1016/S0168‑9525(03)00111‑212801727
     [Google Scholar]
  128. ChenC. MaX. HuQ. LiX. HuangF. ZhangJ. PanT. XiaJ. LiuC. ZhangH. Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin–proteasome pathway.Retrovirology20171415610.1186/s12977‑017‑0382‑129258557
     [Google Scholar]
  129. HeQ. ZhaoL. LiuX. ZhengJ. LiuY. LiuL. MaJ. CaiH. LiZ. XueY. MOV10 binding circ-DICER1 regulates the angiogenesis of glioma via miR-103a-3p/miR-382-5p mediated ZIC4 expression change.J. Exp. Clin. Cancer Res.2019381910.1186/s13046‑018‑0990‑130621721
     [Google Scholar]
  130. LiH. HuheM. LouJ. MicroRNA-103a-3p promotes cell proliferation and invasion in non-small-cell lung cancer cells through Akt pathway by targeting PTEN.BioMed Res. Int.2021202111010.1155/2021/759097634307670
     [Google Scholar]
  131. SunL.P. XuK. CuiJ. YuanD.Y. ZouB. LiJ. LiuJ.L. LiK.Y. MengZ. ZhangB. Cancer-associated fibroblast-derived exosomal miR-382-5p promotes the migration and invasion of oral squamous cell carcinoma.Oncol. Rep.20194241319132810.3892/or.2019.725531364748
     [Google Scholar]
  132. GrinbergI. MillenK.J. The ZIC gene family in development and disease.Clin. Genet.200567429029610.1111/j.1399‑0004.2005.00418.x15733262
     [Google Scholar]
  133. CsermelyP. SchnaiderT. SotiC. ProhászkaZ. NardaiG. The 90-kDa molecular chaperone family: Structure, function, and clinical applications. A comprehensive review.Pharmacol. Ther.199879212916810.1016/S0163‑7258(98)00013‑89749880
     [Google Scholar]
  134. KeH. ZhaoL. FengX. XuH. ZouL. YangQ. SuX. PengL. JiaoB. NEAT1 is required for survival of breast cancer cells through FUS and miR-548.Gene Regul Syst Bio.201610Suppl 11117
     [Google Scholar]
  135. SpitzerJ.I. UgrasS. RungeS. DecarolisP. AntonescuC. TuschlT. SingerS. mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma.Genes Chromosomes Cancer201150533834710.1002/gcc.2085821344536
     [Google Scholar]
  136. YanY. XuZ. ChenX. WangX. ZengS. ZhaoZ. QianL. LiZ. WeiJ. HuoL. LiX. GongZ. SunL. Novel function of lncRNA ADAMTS9-AS2 in promoting temozolomide resistance in glioblastoma via upregulating the FUS/MDM2 ubiquitination axis.Front. Cell Dev. Biol.2019721710.3389/fcell.2019.0021731632968
     [Google Scholar]
  137. JiaoH. FangF. FangT. YouY. FengM. WangX. YinZ. ZhaoW. SOX13 regulates cancer stem-like properties and tumorigenicity in hepatocellular carcinoma cells.Am. J. Cancer Res.202111376077233791152
     [Google Scholar]
  138. MaH.M. YuM. WuC. HuangH.B. LiY.W. ZhangP. HuangJ.J. ChengL. FengG. LiG.R. Overexpression of Spondin-2 is associated with recurrence-free survival in patients with localized clear cell renal cell carcinoma.Dis. Markers2020202011110.1155/2020/507423932952742
     [Google Scholar]
  139. ZhangD. LiuX. ZhangQ. ChenX. miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1.Cancer Cell Int.202020129710.1186/s12935‑020‑01386‑632669973
     [Google Scholar]
  140. ZhengJ. LiuX. XueY. GongW. MaJ. XiZ. QueZ. LiuY. TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1β/Derlin-1 pathway.J. Hematol. Oncol.20171015210.1186/s13045‑017‑0422‑228049484
     [Google Scholar]
  141. HeZ. RuanX. LiuX. ZhengJ. LiuY. LiuL. MaJ. ShaoL. WangD. ShenS. YangC. XueY. FUS/circ_002136/miR-138-5p/SOX13 feedback loop regulates angiogenesis in Glioma.J. Exp. Clin. Cancer Res.20193816510.1186/s13046‑019‑1065‑730736838
     [Google Scholar]
  142. DiL. ZhaoX. DingJ. Knockdown of circ_0008344 contributes to radiosensitization in glioma via miR-433-3p/RNF2 axis.J. Biosci.20214638210.1007/s12038‑021‑00198‑834423784
     [Google Scholar]
  143. WangY. GaoR. LiJ. TangS. LiS. TongQ. MaoY. Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis.Aging202012109793980610.18632/aging.10324432464601
     [Google Scholar]
  144. ZhouJ. WangH. ChuJ. HuangQ. LiG. YanY. XuT. ChenJ. WangY. Circular RNA hsa_circ_0008344 regulates glioblastoma cell proliferation, migration, invasion, and apoptosis.J. Clin. Lab. Anal.2018327e2245410.1002/jcla.2245429687495
     [Google Scholar]
  145. NiJ. LiangS. ShanB. TianW. WangH. RenY. Methylation-associated silencing of miR-638 promotes endometrial carcinoma progression by targeting MEF2C.Int. J. Mol. Med.20204561753177010.3892/ijmm.2020.454032186750
     [Google Scholar]
  146. ZhengD.H. WangX. LuL.N. ChenD.L. ChenJ.M. LinF.M. XuX.B. MiR-638 serves as a tumor suppressor by targeting HOXA9 in glioma.Eur. Rev. Med. Pharmacol. Sci.201822227798780630536324
     [Google Scholar]
  147. ZhaoN. ZhangG. HeM. HuangH. CaoL. YinA. WangP. WangL. SZRD1 is a novel protein that functions as a potential tumor suppressor in cervical cancer.J. Cancer20178112132214110.7150/jca.1880628819415
     [Google Scholar]
  148. DengL. GongK. WangG. Hsa_circ_0008344 promotes glioma tumor progression and angiogenesis presumably by regulating miR-638/SZRD1 pathway.Neurotox. Res.202240382583610.1007/s12640‑022‑00504‑835394558
     [Google Scholar]
  149. ZhengX. PengQ. WangL. ZhangX. HuangL. WangJ. QinZ. Serine/arginine-rich splicing factors: The bridge linking alternative splicing and cancer.Int. J. Biol. Sci.202016132442245310.7150/ijbs.4675132760211
     [Google Scholar]
  150. LeeY. SamacoR.C. GatchelJ.R. ThallerC. OrrH.T. ZoghbiH.Y. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis.Nat. Neurosci.200811101137113910.1038/nn.218318758459
     [Google Scholar]
  151. AsherM. JohnsonA. ZecevicB. PeaseD. CvetanovicM. Ataxin-1 regulates proliferation of hippocampal neural precursors.Neuroscience2016322546510.1016/j.neuroscience.2016.02.01126876606
     [Google Scholar]
  152. WuM. LiX. LiuQ. XieY. YuanJ. WanggouS. miR-526b-3p serves as a prognostic factor and regulates the proliferation, invasion, and migration of glioma through targeting WEE1.Cancer Manag. Res.2019113099311010.2147/CMAR.S19236131114353
     [Google Scholar]
  153. LiuX. ShenS. ZhuL. SuR. ZhengJ. RuanX. ShaoL. WangD. YangC. LiuY. SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway.J. Exp. Clin. Cancer Res.202039112110.1186/s13046‑020‑01625‑832600379
     [Google Scholar]
  154. GuanY. CaoZ. DuJ. LiuT. WangT. Circular RNA circPITX1 knockdown inhibits glycolysis to enhance radiosensitivity of glioma cells by miR-329-3p/NEK2 axis.Cancer Cell Int.20202018010.1186/s12935‑020‑01169‑z32190004
     [Google Scholar]
  155. CaoY. WangF. ChenY. WangY. SongH. LongJ. CircPITX1 regulates proliferation, angiogenesis, migration, invasion, and cell cycle of human glioblastoma cells by targeting miR-584-5p/KPNB1 axis.J. Mol. Neurosci.20217181683169510.1007/s12031‑021‑01820‑y33763840
     [Google Scholar]
  156. AbdelfattahN. RajamanickamS. PanneerdossS. TimilsinaS. YadavP. OnyeaguchaB.C. GarciaM. VadlamudiR. ChenY. BrennerA. HoughtonP. RaoM.K. MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastoma.Nat. Commun.201891454110.1038/s41467‑018‑06808‑830382096
     [Google Scholar]
  157. StelmaT. LeanerV.D. KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells.Oncotarget2017820328333284710.18632/oncotarget.1583428427184
     [Google Scholar]
  158. ZhuZ.C. LiuJ.W. LiK. ZhengJ. XiongZ.Q. KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.Oncogene201837222936295210.1038/s41388‑018‑0180‑929520102
     [Google Scholar]
  159. RynkevicieneR. SimieneJ. StrainieneE. StankeviciusV. UsinskieneJ. Miseikyte KaubrieneE. MeskinyteI. CicenasJ. SuziedelisK. Non-coding RNAs in glioma.Cancers20181111710.3390/cancers1101001730583549
     [Google Scholar]
  160. MizoguchiM. GuanY. YoshimotoK. HataN. AmanoT. NakamizoA. SasakiT. Clinical implications of microRNAs in human glioblastoma.Front. Oncol.201331910.3389/fonc.2013.0001923403472
     [Google Scholar]
  161. NikakiA. PiperiC. PapavassiliouA.G. Role of microRNAs in gliomagenesis: Targeting miRNAs in glioblastoma multiforme therapy.Expert Opin. Investig. Drugs201221101475148810.1517/13543784.2012.71019922809292
     [Google Scholar]
  162. QadirM.I. BukhatS. RasulS. ManzoorH. ManzoorM. RNA therapeutics: Identification of novel targets leading to drug discovery.J. Cell. Biochem.2020121289892910.1002/jcb.2936431478252
     [Google Scholar]
  163. ZhouY. ZhouG. TianC. JiangW. JinL. ZhangC. ChenX. Exosome-mediated small RNA delivery for gene therapy.Wiley Interdiscip. Rev. RNA20167675877110.1002/wrna.136327196002
     [Google Scholar]
  164. ZhouJ. AtsinaK.B. HimesB.T. StrohbehnG.W. SaltzmanW.M. Novel delivery strategies for glioblastoma.Cancer J.2012181899910.1097/PPO.0b013e318244d8ae22290262
     [Google Scholar]
  165. HadjipanayisC.G. MachaidzeR. KaluzovaM. WangL. SchuetteA.J. ChenH. WuX. MaoH. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.Cancer Res.201070156303631210.1158/0008‑5472.CAN‑10‑102220647323
     [Google Scholar]
  166. FanQ. YangL. ZhangX. PengX. WeiS. SuD. ZhaiZ. HuaX. LiH. The emerging role of exosome-derived non-coding RNAs in cancer biology.Cancer Lett.201841410711510.1016/j.canlet.2017.10.04029107112
     [Google Scholar]
  167. Alvarez-ErvitiL. SeowY. YinH. BettsC. LakhalS. WoodM.J.A. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.Nat. Biotechnol.201129434134510.1038/nbt.180721423189
     [Google Scholar]
  168. AiliY. MaimaitimingN. MahemutiY. QinH. WangY. WangZ. The role of exosomal miRNAs in glioma: Biological function and clinical application.Front. Oncol.20211168636910.3389/fonc.2021.68636934540663
     [Google Scholar]
  169. WinkleM. El-DalyS.M. FabbriM. CalinG.A. Noncoding RNA therapeutics-challenges and potential solutions.Nat. Rev. Drug Discov.202120862965110.1038/s41573‑021‑00219‑z34145432
     [Google Scholar]
  170. MalikS.S. MasoodN. SherrardA. BishopP.N. Small non-coding RNAs as a tool for personalized therapy in familial cancers, AGO-Driven Non-Coding RNAs.Elsevier2019179208
     [Google Scholar]
  171. YadavB. PalS. RubstovY. GoelA. GargM. PavlyukovM. PandeyA.K. LncRNAs associated with glioblastoma: From transcriptional noise to novel regulators with a promising role in therapeutics.Mol. Ther. Nucleic Acids20212472874210.1016/j.omtn.2021.03.01833996255
     [Google Scholar]
  172. SchultzN. MarensteinD.R. De AngelisD.A. WangW.Q. NelanderS. JacobsenA. MarksD.S. MassaguéJ. SanderC. Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-β pathway and reveal microRNA regulation of TGFBR2.Silence201121310.1186/1758‑907X‑2‑321401928
     [Google Scholar]
  173. JulianoR.L. The delivery of therapeutic oligonucleotides.Nucleic Acids Res.201644146518654810.1093/nar/gkw23627084936
     [Google Scholar]
  174. DrazM.S. FangB.A. ZhangP. HuZ. GuS. WengK.C. GrayJ.W. ChenF.F. Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.Theranostics20144987289210.7150/thno.940425057313
     [Google Scholar]
  175. SettenR.L. RossiJ.J. HanS. The current state and future directions of RNAi-based therapeutics.Nat. Rev. Drug Discov.201918642144610.1038/s41573‑019‑0017‑430846871
     [Google Scholar]
/content/journals/cmc/10.2174/0109298673259378231031061149
Loading
Recent Insights into the Angioregulatory Role of Long Non-coding RNAs and Circular RNAs in Gliomas: From Signaling Pathways to Clinical Aspects
Curr. Med. Chem. 32, 3169 (2025); https://doi.org/10.2174/0109298673259378231031061149
/content/journals/cmc/10.2174/0109298673259378231031061149
/content/journals/cmc/10.2174/0109298673259378231031061149
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Angiogenesis; circular RNAs; GBM; Glioma; long non-coding RNAs; signaling pathways

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test